{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,9,12]],"date-time":"2026-09-12T09:08:04Z","timestamp":1789204084266,"version":"build-2803163510"},"reference-count":42,"publisher":"Elsevier BV","issue":"10","license":[{"start":{"date-parts":[[2006,10,1]],"date-time":"2006-10-01T00:00:00Z","timestamp":1159660800000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"}],"content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":["Clinical Therapeutics"],"published-print":{"date-parts":[[2006,10]]},"DOI":"10.1016\/j.clinthera.2006.10.005","type":"journal-article","created":{"date-parts":[[2006,12,6]],"date-time":"2006-12-06T12:11:17Z","timestamp":1165407077000},"page":"1607-1618","source":"Crossref","is-referenced-by-count":26,"title":["Dextromethorphan and quinidine in adult patients with uncontrolled painful diabetic peripheral neuropathy: A 29-day, multicenter, open-Label, dose-escalation study"],"prefix":"10.1016","volume":"28","author":[{"given":"Ronald A.","family":"Thisted","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Leslie","family":"Klaff","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Sherwyn L.","family":"Schwartz","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"James P.","family":"Wymer","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Neil W.","family":"Culligan","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Gary","family":"Gerard","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Laura E.","family":"Pope","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"James E.","family":"Berg","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"78","reference":[{"key":"10.1016\/j.clinthera.2006.10.005_bib1","doi-asserted-by":"crossref","first-page":"737","DOI":"10.2165\/00002512-200118100-00003","article-title":"Management of painful diabetic neuropathy","volume":"18","author":"Jensen","year":"2001","journal-title":"Drugs Aging"},{"key":"10.1016\/j.clinthera.2006.10.005_bib2","doi-asserted-by":"crossref","first-page":"150","DOI":"10.1007\/BF00400697","article-title":"A multicentre study of the prevalence of diabetic peripheral neuropathy in the United Kingdom hospital clinic population","volume":"36","author":"Young","year":"1993","journal-title":"Diabetologia"},{"key":"10.1016\/j.clinthera.2006.10.005_bib3","doi-asserted-by":"crossref","first-page":"169","DOI":"10.1007\/s11916-003-0070-9","article-title":"Pharmacotherapy of painful diabetic neuropathy","volume":"7","author":"Barbaro","year":"2003","journal-title":"Curr Pain Headache Rep"},{"key":"10.1016\/j.clinthera.2006.10.005_bib4","doi-asserted-by":"crossref","first-page":"1439","DOI":"10.1016\/S0025-7125(16)30716-7","article-title":"Peripheral diabetic neuropathy","volume":"72","author":"Bays","year":"1988","journal-title":"Med Clin North Am"},{"key":"10.1016\/j.clinthera.2006.10.005_bib5","series-title":"Textbook of Pain","first-page":"79","article-title":"The pathophysiology of damaged peripheral nerves","author":"Devor","year":"1994"},{"key":"10.1016\/j.clinthera.2006.10.005_bib6","doi-asserted-by":"crossref","first-page":"259","DOI":"10.1016\/0304-3959(93)90161-H","article-title":"Contribution of central neuroplasticity to pathological pain: Review of clinical and experimental evidence","volume":"52","author":"Coderre","year":"1993","journal-title":"Pain"},{"key":"10.1016\/j.clinthera.2006.10.005_bib7","doi-asserted-by":"crossref","first-page":"95","DOI":"10.1016\/0006-8993(81)91174-4","article-title":"The effect of peripheral nerve injury on dorsal root potentials and on transmission of afferent signals into the spinal cord","volume":"209","author":"Wall","year":"1981","journal-title":"Brain Res"},{"key":"10.1016\/j.clinthera.2006.10.005_bib8","doi-asserted-by":"crossref","first-page":"75","DOI":"10.1038\/355075a0","article-title":"Peripheral nerve injury triggers central sprouting of myelinated afferents","volume":"355","author":"Woolf","year":"1992","journal-title":"Nature"},{"key":"10.1016\/j.clinthera.2006.10.005_bib9","doi-asserted-by":"crossref","first-page":"1524","DOI":"10.1001\/archneur.60.11.1524","article-title":"Advances in neuropathic pain: Diagnosis, mechanisms, and treatment recommendations","volume":"60","author":"Dworkin","year":"2003","journal-title":"Arch Neurol"},{"key":"10.1016\/j.clinthera.2006.10.005_bib10","first-page":"512","article-title":"Consensus guidelines: Treatment planning and options. Diabetic peripheral neuropathic pain","volume":"81","author":"Argoff","year":"2006"},{"key":"10.1016\/j.clinthera.2006.10.005_bib11","doi-asserted-by":"crossref","first-page":"156","DOI":"10.1016\/j.pain.2006.01.030","article-title":"Epidemiology and treatment of neuropathic pain: The UK primary care perspective","volume":"122","author":"Hall","year":"2006","journal-title":"Pain"},{"key":"10.1016\/j.clinthera.2006.10.005_bib12","first-page":"1","article-title":"Effects ofdextromethorphan site ligands and allosteric modifiers on the binding of (+)-[3H]3-(-3-hydroxyphenyl)-N-(1-propyl)piperidine","volume":"35","author":"Musacchio","year":"1989","journal-title":"Mol Pharmacol"},{"key":"10.1016\/j.clinthera.2006.10.005_bib13","doi-asserted-by":"crossref","first-page":"1303","DOI":"10.1016\/0028-3908(91)90027-9","article-title":"Dextromethorphan and levorphanol on dorsal horn nociceptive neurones in the rat","volume":"30","author":"Dickenson","year":"1991","journal-title":"Neuropharmacology"},{"key":"10.1016\/j.clinthera.2006.10.005_bib14","doi-asserted-by":"crossref","first-page":"268","DOI":"10.1245\/ASO.2003.08.007","article-title":"Dextromethorphan mitigates phantom pain in cancer amputees","volume":"10","author":"Ben Abraham","year":"2003","journal-title":"Ann Surg Oncol"},{"key":"10.1016\/j.clinthera.2006.10.005_bib15","doi-asserted-by":"crossref","first-page":"261","DOI":"10.1016\/S0304-3959(01)00455-9","article-title":"Analgesic effects of dextromethorphan and morphine in patients with chronic pain","volume":"96","author":"Heiskanen","year":"2002","journal-title":"Pain"},{"key":"10.1016\/j.clinthera.2006.10.005_bib16","doi-asserted-by":"crossref","first-page":"1212","DOI":"10.1212\/WNL.48.5.1212","article-title":"High-dose oral dextromethorphan versus placebo in painful dia betic neuropathy and postherpetic neuralgia","volume":"48","author":"Nelson","year":"1997","journal-title":"Neurology"},{"issue":"Suppl 1","key":"10.1016\/j.clinthera.2006.10.005_bib17","doi-asserted-by":"crossref","first-page":"S21","DOI":"10.1016\/S0885-3924(99)00125-6","article-title":"NMDA-receptor antagonists in neuropathic pain: Experimental methods to clinical trials","volume":"19","author":"Sang","year":"2000","journal-title":"J Pain Symptom Manage"},{"key":"10.1016\/j.clinthera.2006.10.005_bib18","doi-asserted-by":"crossref","first-page":"1053","DOI":"10.1097\/00000542-200205000-00005","article-title":"Dextromethorphan and memantine in painful diabetic neuropathy and post-herpetic neuralgia: Efficacy and dose-response trials","volume":"96","author":"Sang","year":"2002","journal-title":"Anesthesiology"},{"key":"10.1016\/j.clinthera.2006.10.005_bib19","first-page":"392","article-title":"Dextromethorphan Odemethylation and dextrorphan glu curonidation in a French population","volume":"31","author":"Duche","year":"1993","journal-title":"Int J Clin Pharmacol Ther Toxicol"},{"key":"10.1016\/j.clinthera.2006.10.005_bib20","first-page":"768","article-title":"Blood-brain barrier permeability to morphine-6-glucuronide is markedly reduced compared with morphine","volume":"25","author":"Wu","year":"1997","journal-title":"Drug Metab Dispos"},{"key":"10.1016\/j.clinthera.2006.10.005_bib21","series-title":"Quinidine sulfate","year":"2005"},{"key":"10.1016\/j.clinthera.2006.10.005_bib22","doi-asserted-by":"crossref","first-page":"35","DOI":"10.1056\/NEJM199801013380107","article-title":"Quinidine","volume":"338","author":"Grace","year":"1998","journal-title":"N Engl J Med"},{"key":"10.1016\/j.clinthera.2006.10.005_bib23","doi-asserted-by":"crossref","first-page":"199","DOI":"10.1111\/j.1365-2125.1986.tb05251.x","article-title":"Quinidine: Potent inhibition of sparteine and debrisoquine oxidation in vivo","volume":"22","author":"Inaba","year":"1986","journal-title":"Br J Clin Pharmacol"},{"key":"10.1016\/j.clinthera.2006.10.005_bib24","doi-asserted-by":"crossref","first-page":"1132","DOI":"10.1177\/0091270004269521","article-title":"Pharmacokinetics of dextromethorphan after single or multiple dosing in combination with quinidine in extensive and poor metabolizers","volume":"44","author":"Pope","year":"2004","journal-title":"J Clin Pharmacol"},{"key":"10.1016\/j.clinthera.2006.10.005_bib25","doi-asserted-by":"crossref","first-page":"1364","DOI":"10.1212\/01.WNL.0000142042.50528.2F","article-title":"Treatment of pseudobulbar affect in ALS with dextromethorphan\/ quinidine: A randomized trial","volume":"637","author":"Brooks","year":"2004","journal-title":"Neurology"},{"key":"10.1016\/j.clinthera.2006.10.005_bib26","doi-asserted-by":"crossref","first-page":"780","DOI":"10.1002\/ana.20828","article-title":"Randomized, controlled trial of dextromethorphan\/quinidine for pseudobulbar affect in multiple sclerosis","volume":"59","author":"Panitch","year":"2006","journal-title":"Ann Neurol"},{"key":"10.1016\/j.clinthera.2006.10.005_bib27","doi-asserted-by":"crossref","first-page":"191","DOI":"10.1016\/0304-3959(87)91074-8","article-title":"The short-form McGill Pain Questionnaire","volume":"30","author":"Melzack","year":"1987","journal-title":"Pain"},{"key":"10.1016\/j.clinthera.2006.10.005_bib28","doi-asserted-by":"crossref","first-page":"406","DOI":"10.1016\/S0885-3924(03)00162-3","article-title":"Clinically important changes in acute pain outcome measures: A valida tion study","volume":"25","author":"Farrar","year":"2003","journal-title":"J Pain Symptom Manage"},{"key":"10.1016\/j.clinthera.2006.10.005_bib29","doi-asserted-by":"crossref","first-page":"93","DOI":"10.1177\/154596830001400202","article-title":"Development of a health-related quality of life measure for peripheral neuropathy","volume":"14","author":"Vickrey","year":"2000","journal-title":"Neurorehabil Neural Repair"},{"key":"10.1016\/j.clinthera.2006.10.005_bib30","first-page":"129","article-title":"Pain assessment: Global use of the Brief Pain Inventory","volume":"23","author":"Cleeland","year":"1994","journal-title":"Ann Acad Med Singapore"},{"key":"10.1016\/j.clinthera.2006.10.005_bib31","doi-asserted-by":"crossref","first-page":"196","DOI":"10.1016\/0885-3924(92)90075-S","article-title":"A comparison of the Hopkins Pain Rating Instrument with standard visual analogue and verbal descriptor scales in patients with cancer pain","volume":"7","author":"Grossman","year":"1992","journal-title":"J Pain Symptom Manage"},{"key":"10.1016\/j.clinthera.2006.10.005_bib32","doi-asserted-by":"crossref","first-page":"239","DOI":"10.1016\/S0885-3924(01)00409-2","article-title":"Pain measurement tools and methods in clinical research in pal liative care: Recommendations of an Expert Working Group of the European Association of Palliative Care","volume":"23","author":"Caraceni","year":"2002","journal-title":"J Pain Symptom Manage"},{"key":"10.1016\/j.clinthera.2006.10.005_bib33","series-title":"BiostatisticalAnalysis","first-page":"413","article-title":"Multiple regression and correlation","author":"Zar","year":"1999"},{"key":"10.1016\/j.clinthera.2006.10.005_bib34","series-title":"Biostatistical Analysis","first-page":"91","article-title":"One-sample hypotheses","author":"Zar","year":"1999"},{"key":"10.1016\/j.clinthera.2006.10.005_bib35","series-title":"Applied Longitudinal Analysis","first-page":"291","article-title":"Marginal models: Generalized Estimating Equations (GEE)","author":"Fitzmaurice","year":"2004"},{"key":"10.1016\/j.clinthera.2006.10.005_bib36","doi-asserted-by":"crossref","first-page":"429","DOI":"10.2307\/2986270","article-title":"Regression using fractional polynomials of continuous covariates: Parsimonious parametric modelling","volume":"43","author":"Royston","year":"1994","journal-title":"Appl Stat"},{"key":"10.1016\/j.clinthera.2006.10.005_bib37","doi-asserted-by":"crossref","first-page":"404","DOI":"10.1093\/biomet\/26.4.404","article-title":"The use of confidence or fiducial limits illustrated in the case of the binomial","volume":"26","author":"Clopper","year":"1934","journal-title":"Biometrika"},{"key":"10.1016\/j.clinthera.2006.10.005_bib38","doi-asserted-by":"crossref","first-page":"1831","DOI":"10.1001\/jama.280.21.1831","article-title":"Gabapentin for the symptomatic treatment of painful neu ropathy in patients with diabetes mellitus: A randomized controlled tria","volume":"280","author":"Backonja","year":"1998","journal-title":"JAMA"},{"key":"10.1016\/j.clinthera.2006.10.005_bib39","doi-asserted-by":"crossref","first-page":"127","DOI":"10.1016\/0304-3959(94)90056-6","article-title":"Dextromethorphan for the treatment of neuropathic pain: A doubleblind randomised controlled crossover trial with integral n-of-1 design","volume":"59","author":"McQuay","year":"1994","journal-title":"Pain"},{"key":"10.1016\/j.clinthera.2006.10.005_bib40","doi-asserted-by":"crossref","first-page":"325","DOI":"10.1097\/00008571-199808000-00006","article-title":"Comparison of three CYP2D6 probe substrates and genotype in Ghanaians, Chinese and Caucasians","volume":"8","author":"Droll","year":"1998","journal-title":"Pharma cogenetics"},{"key":"10.1016\/j.clinthera.2006.10.005_bib41","doi-asserted-by":"crossref","first-page":"607","DOI":"10.1016\/S0022-3565(24)37996-0","article-title":"Contribution of cytochrome P-4502D6 phenotype to the neuromodulatory effects of dextromethorphan","volume":"288","author":"Desmeules","year":"1999","journal-title":"J Pharmacol Exp Ther"},{"key":"10.1016\/j.clinthera.2006.10.005_bib42","doi-asserted-by":"crossref","first-page":"187","DOI":"10.1111\/j.1365-2125.1981.tb01123.x","article-title":"The effect of quinidine and its metabolites on the electro cardiogram and systolic time intervals: Concentration-effect relationships","volume":"11","author":"Holford","year":"1981","journal-title":"Br J Clin Pharmacol"}],"container-title":["Clinical Therapeutics"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0149291806002451?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0149291806002451?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2025,1,12]],"date-time":"2025-01-12T07:15:14Z","timestamp":1736666114000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S0149291806002451"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2006,10]]},"references-count":42,"journal-issue":{"issue":"10","published-print":{"date-parts":[[2006,10]]}},"alternative-id":["S0149291806002451"],"URL":"https:\/\/doi.org\/10.1016\/j.clinthera.2006.10.005","relation":{},"ISSN":["0149-2918"],"issn-type":[{"value":"0149-2918","type":"print"}],"subject":[],"published":{"date-parts":[[2006,10]]}}}